[go: up one dir, main page]

IT9048102A0 - Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono - Google Patents

Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono

Info

Publication number
IT9048102A0
IT9048102A0 IT9048102A IT4810290A IT9048102A0 IT 9048102 A0 IT9048102 A0 IT 9048102A0 IT 9048102 A IT9048102 A IT 9048102A IT 4810290 A IT4810290 A IT 4810290A IT 9048102 A0 IT9048102 A0 IT 9048102A0
Authority
IT
Italy
Prior art keywords
immunomodulant
hypoxanthine
activity
contain
pharmaceutical compositions
Prior art date
Application number
IT9048102A
Other languages
English (en)
Other versions
IT1241452B (it
IT9048102A1 (it
Inventor
Mauro Marzi
Patrizia Minetti
Piero Foresta
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of IT9048102A0 publication Critical patent/IT9048102A0/it
Priority to IT48102A priority Critical patent/IT1241452B/it
Priority to DK91830284T priority patent/DK0464009T3/da
Priority to DE69129387T priority patent/DE69129387T2/de
Priority to EP91830284A priority patent/EP0464009B1/en
Priority to AT91830284T priority patent/ATE166063T1/de
Priority to ES91830284T priority patent/ES2117003T3/es
Priority to US07/723,418 priority patent/US5298621A/en
Priority to JP3158342A priority patent/JPH04230298A/ja
Publication of IT9048102A1 publication Critical patent/IT9048102A1/it
Application granted granted Critical
Publication of IT1241452B publication Critical patent/IT1241452B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IT48102A 1990-06-28 1990-06-28 Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono IT1241452B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT48102A IT1241452B (it) 1990-06-28 1990-06-28 Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
AT91830284T ATE166063T1 (de) 1990-06-28 1991-06-26 Mit ipoxantin ausgestattete oligopeptidderivate mit immunomodulatorischer wirksamkeit und diese enthaltende pharmazeutische zusammensetzungen
DE69129387T DE69129387T2 (de) 1990-06-28 1991-06-26 Mit Ipoxantin ausgestattete Oligopeptidderivate mit immunomodulatorischer Wirksamkeit und diese enthaltende pharmazeutische Zusammensetzungen
EP91830284A EP0464009B1 (en) 1990-06-28 1991-06-26 Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same
DK91830284T DK0464009T3 (da) 1990-06-28 1991-06-26 Oligopeptidderivater af ipoxantin udstyret med immunomodulerende aktivitet, og farmaceutiske præparater indeholdende samme
ES91830284T ES2117003T3 (es) 1990-06-28 1991-06-26 Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
US07/723,418 US5298621A (en) 1990-06-28 1991-06-28 Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same
JP3158342A JPH04230298A (ja) 1990-06-28 1991-06-28 ヒポキサンチンオリゴペプチド誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48102A IT1241452B (it) 1990-06-28 1990-06-28 Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
IT9048102A0 true IT9048102A0 (it) 1990-06-28
IT9048102A1 IT9048102A1 (it) 1991-12-28
IT1241452B IT1241452B (it) 1994-01-17

Family

ID=11264531

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48102A IT1241452B (it) 1990-06-28 1990-06-28 Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono

Country Status (8)

Country Link
US (1) US5298621A (it)
EP (1) EP0464009B1 (it)
JP (1) JPH04230298A (it)
AT (1) ATE166063T1 (it)
DE (1) DE69129387T2 (it)
DK (1) DK0464009T3 (it)
ES (1) ES2117003T3 (it)
IT (1) IT1241452B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU717160B2 (en) * 1994-06-22 2000-03-16 Shire Canada Inc. Novel substituted purinyl derivatives with immunomodulating activity
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
DE19541264A1 (de) * 1995-11-06 1997-05-07 Bayer Ag Purin-6-on-derivate
RU2210382C1 (ru) * 2002-07-09 2003-08-20 Терентьев Александр Александрович Пептид, обладающий иммунорегуляторным свойством, и его композиция
KR100721144B1 (ko) * 2006-03-22 2007-05-25 (주)아르떼르화장품 펩타이드 혼합물을 포함하는 주름개선용 화장료 조성물
FR3021319B1 (fr) 2014-05-22 2018-08-31 Sederma Peptides, compositions les comprenant et utilisations notamment cosmetiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
IT1223604B (it) * 1987-12-24 1990-09-29 Co Pharma Corp Srl Derivati purinici ad azione farmacologica

Also Published As

Publication number Publication date
DE69129387T2 (de) 1998-09-17
EP0464009A2 (en) 1992-01-02
EP0464009B1 (en) 1998-05-13
DE69129387D1 (de) 1998-06-18
EP0464009A3 (en) 1992-06-17
ATE166063T1 (de) 1998-05-15
JPH04230298A (ja) 1992-08-19
US5298621A (en) 1994-03-29
ES2117003T3 (es) 1998-08-01
IT1241452B (it) 1994-01-17
IT9048102A1 (it) 1991-12-28
DK0464009T3 (da) 1999-03-08

Similar Documents

Publication Publication Date Title
NL300136I1 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
ITRM910189A0 (it) Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
IT8149623A0 (it) Derivati encefalinici dotati di attivita' analgesica e composizioni farmaceutiche che li contengono
IT9048102A0 (it) Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
IT8021550A0 (it) Derivati adenosinici ad attivita'antinfiammatoria ed analgesica e composizioni terapeutiche che licontengono come principio attivo.
IT8449056A1 (it) Derivati dell' 1- 2 ditiolano loro preparazione e loro impiego come medicamenti
IT8103423A0 (it) Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono
ITRM910829A0 (it) Derivati dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
IT1173445B (it) Agenti ad attivita' antibroncospastica e composizioni farmaceutiche che li contengono
ITRM920760A0 (it) Derivati amminoacilici e oligopeptidici dell'ipoxantina b-sostituita dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono.
IT8249095A0 (it) Derivati di 4-piridilpiridazinone dotati di attivita' antiinfiammatoria ed analgesica
ITMI913398A1 (it) Derivati dell'eserolina ad attivita' anticolinesterasica procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI912421A0 (it) Derivati eterociclici di alcossiacrilati ad attivita' fungicida
ITMI931082A0 (it) Coniugati di farmaci antivirali ad attivita' epatotropicaq relativi veicolanti e composizioni farmaceutiche che li contengono
ITMI920225A0 (it) Derivati tiazolici di alcossiacrilati ad attivita' fungicida
IT9048605A0 (it) Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
IT1150706B (it) Derivati di eterociclici azotati dotati di attivita' fitoregolatrice
IT1227892B (it) Composizioni farmaceutiche ad attivita' antidepressiva e ansiolitica
IT1232359B (it) Fluoro derivati della 2-amminotetralina e composizioni farmaceutiche ad attivita' antipertensiva che li contengono
ITMI922832A1 (it) DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.
ITMI921950A0 (it) Composizioni farmaceutiche ad attivita' epato-trofica ed anti-aging
IT1173243B (it) Derivati dell'imidazolo e composizioni farmaceutiche che li contengono
ITMI911653A0 (it) Derivati dell'eseridina ad attivita' amticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970515